4BIO Capital
Europe, England, United Kingdom, London'%3e%3cpath fill='%23012169' d='M0 0v30h60V0z'/%3e%3cpath stroke='%23fff' stroke-width='6' d='m0 0 60 30m0-30L0 30'/%3e%3cpath stroke='%23C8102E' stroke-width='4' d='m0 0 60 30m0-30L0 30' clip-path='url(%23b)'/%3e%3cpath stroke='%23fff' stroke-width='10' d='M30 0v30M0 15h60'/%3e%3cpath stroke='%23C8102E' stroke-width='6' d='M30 0v30M0 15h60'/%3e%3c/g%3e%3c/svg%3e)
Description
4BIO Capital is a specialist fund focused on investing in and building early stage advanced therapy companies
Investor Profile
4BIO Capital has backed more than 17 startups, with 1 new investments in the last 12 months alone. The firm has led 7 rounds, about 41% of its total and boasts 6 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Series A, Series B, Series C rounds (top funding stages).
- Majority of deals are located in United States, United Kingdom, Switzerland.
- Strong thematic focus on Biotechnology, Health Care, Life Science.
- Led 1 rounds in the past year.
Stage Focus
- Series A (53%)
- Series B (24%)
- Series C (12%)
- Seed (12%)
Country Focus
- United States (47%)
- United Kingdom (18%)
- Switzerland (18%)
- France (12%)
- Japan (6%)
Industry Focus
- Biotechnology
- Health Care
- Life Science
- Medical
- Therapeutics
- Biopharma
- Pharmaceutical
- Genetics
- Health Diagnostics
- Consulting
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
'/%3e%3cuse xlink:href='%23a' transform='rotate(23.036 .093 25.536)'/%3e%3cuse xlink:href='%23a' transform='rotate(45.87 1.273 16.18)'/%3e%3cuse xlink:href='%23a' transform='rotate(69.945 .996 12.078)'/%3e%3cuse xlink:href='%23a' transform='rotate(20.66 -19.689 31.932)'/%3e%3c/svg%3e)
